Literature DB >> 19830274

5',8-Cyclo-2'-deoxyadenosine (cdA) formation by gamma-radiation. Theoretical quantum mechanics study.

Boleslaw T Karwowski1, Andre Grand, Jean Cadet.   

Abstract

Reactions of reactive oxygen species and more specifically - of hydroxyl radical ((*)OH) - with nucleosides may lead to the generation of radicals in the base and 2-deoxyribose moieties. In the present study emphasis was put on the possible reaction modes of 2'-deoxyadenosine (dA) radicals, leading to the formation of related 5',8-cyclonucleosides. It appears that the prerequisite for the formation of 5',8-cyclo-2'-deoxyadenosine (cdA) is the adoption of O4'-exo conformation by 2-deoxyribose; however, this is the least energetically favored conformer among the different puckered forms adopted by the furanose ring. The O4'-exo conformation was found to be present in each of the discussed mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19830274

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  3 in total

1.  Structural basis for the recognition of diastereomeric 5',8-cyclo-2'-deoxypurine lesions by the human nucleotide excision repair system.

Authors:  Konstantin Kropachev; Shuang Ding; Michael A Terzidis; Annalisa Masi; Zhi Liu; Yuqin Cai; Marina Kolbanovskiy; Chryssostomos Chatgilialoglu; Suse Broyde; Nicholas E Geacintov; Vladimir Shafirovich
Journal:  Nucleic Acids Res       Date:  2014-03-10       Impact factor: 16.971

2.  Clustered DNA Damage: Electronic Properties and Their Influence on Charge Transfer. 7,8-Dihydro-8-Oxo-2'-Deoxyguaosine Versus 5',8-Cyclo-2'-Deoxyadenosines: A Theoretical Approach.

Authors:  Boleslaw T Karwowski
Journal:  Cells       Date:  2020-02-12       Impact factor: 6.600

3.  The Influence of (5'R)- and (5'S)-5',8-Cyclo-2'-Deoxyadenosine on UDG and hAPE1 Activity. Tandem Lesions are the Base Excision Repair System's Nightmare.

Authors:  Bolesław T Karwowski
Journal:  Cells       Date:  2019-10-23       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.